blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1071447

EP1071447 - Gastrin for use in the treatment of diabetes [Right-click to bookmark this link]
Former [2001/05]TREATMENT FOR DIABETES
[2009/09]
StatusThe application is deemed to be withdrawn
Status updated on  15.10.2010
Database last updated on 03.10.2024
Most recent event   Tooltip15.10.2010Application deemed to be withdrawnpublished on 17.11.2010  [2010/46]
Applicant(s)For all designated states
WARATAH PHARMACEUTICALS INC.
1000 Chemin du Golf Iles des Soeurs
Verdun, Quebec / CA
For all designated states
THE GENERAL HOSPITAL CORPORATION
55 Fruit Street
Boston, MA 02114 / US
[N/P]
Former [2001/05]For all designated states
WARATAH PHARMACEUTICALS INC.
1000 Chemin du Golf Iles des Soeurs
Verdun, Quebec / CA
For all designated states
THE GENERAL HOSPITAL CORPORATION
55 Fruit Street
Boston, MA 02114 / US
Inventor(s)01 / PARIKH, Indu
2558 Booker Creek Road
Chapel Hill, NC 27514 / US
02 / LANE, Anne, UCL Ventures
Brooks House, 2-16 Torrington Place
London WC1E 1HN / GB
03 / NARDI, Ronald, V.
32 Hutton Drive
Mahwah, NJ 07430 / US
04 / BRAND, Stephen, J.
161 Bedford Road
Lincoln, MA 01773 / US
 [2001/31]
Former [2001/05]01 / PARIKH, Indu
2558 Booker Creek Road
Chapel Hill, NC 27514 / US
02 / LANE, Anne
266 Lansdowne Road
Westmount, Quebec H3Z 2L3 / CA
03 / NARDI, Ronald, V.
32 Hutton Drive
Mahwah, NJ 07430 / US
04 / BRAND, Stephen, J.
161 Bedford Road
Lincoln, MA 01773 / US
Representative(s)Harding, Charles Thomas, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2009/26]Harding, Charles Thomas, et al
D Young & Co 120 Holborn London
EC1N 2DY / GB
Former [2008/24]Harding, Charles Thomas, et al
D Young & Co 120 Holborn
London EC1N 2DY / GB
Former [2006/25]Holliday, Louise Caroline, et al
D Young & Co 120 Holborn
London EC1N 2DY / GB
Former [2006/19]Richards, William John, et al
D. Young & Co. Briton House Briton Street
GB-Southampton S014 3EB / GB
Former [2001/05]Prins, Adrianus Willem, et al
Vereenigde, Nieuwe Parklaan 97
2587 BN Den Haag / NL
Application number, filing date99956786.027.10.1999
[2001/05]
WO1999US25463
Priority number, dateUS1999024110029.01.1999         Original published format: US 241100
[2001/05]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0044400
Date:03.08.2000
Language:EN
[2000/31]
Type: A1 Application with search report 
No.:EP1071447
Date:31.01.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 03.08.2000 takes the place of the publication of the European patent application.
[2001/05]
Search report(s)International search report - published on:EP03.08.2000
ClassificationIPC:A61K38/22, A61K35/39, A61P5/48
[2010/04]
CPC:
C07K14/495 (EP,SE,US); A61K38/18 (SE); A61K38/27 (KR);
A61K38/1841 (SE); A61K38/2207 (EP,SE,US); A61P3/10 (EP);
A61P43/00 (EP); A61P5/48 (EP); A61P7/00 (EP);
C07K14/595 (EP,SE,US); A61K48/00 (EP,US) (-)
C-Set:
A61K38/2207, A61K2300/00 (US,EP);
A61K38/2207, A61K38/1808 (EP,US);
A61K38/2207, A61K38/1841 (US,EP)
Former IPC [2001/05]A61K38/22, A61K35/39, A61P5/48, // A61K38:22, A61K38:18
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/05]
TitleGerman:Gastrin zur Behandlung von Diabetes[2009/09]
English:Gastrin for use in the treatment of diabetes[2009/09]
French:Gastrine pour traitement du diabete[2009/09]
Former [2001/05]DIABETESBEHANDLUNG
Former [2001/05]TREATMENT FOR DIABETES
Former [2001/05]TRAITEMENT DU DIABETE
Entry into regional phase27.10.2000National basic fee paid 
27.10.2000Designation fee(s) paid 
05.02.2001Examination fee paid 
Examination procedure05.02.2001Examination requested  [2001/14]
06.02.2003Despatch of a communication from the examining division (Time limit: M04)
12.06.2003Reply to a communication from the examining division
20.01.2004Despatch of a communication from the examining division (Time limit: M06)
27.07.2004Reply to a communication from the examining division
20.04.2005Despatch of a communication from the examining division (Time limit: M06)
27.10.2005Reply to a communication from the examining division
02.02.2007Despatch of a communication from the examining division (Time limit: M04)
22.03.2007Reply to a communication from the examining division
08.01.2010Communication of intention to grant the patent
19.05.2010Application deemed to be withdrawn, date of legal effect  [2010/46]
28.06.2010Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2010/46]
Fees paidRenewal fee
14.01.2002Renewal fee patent year 03
31.10.2002Renewal fee patent year 04
17.10.2003Renewal fee patent year 05
18.10.2004Renewal fee patent year 06
17.10.2005Renewal fee patent year 07
12.10.2006Renewal fee patent year 08
15.10.2007Renewal fee patent year 09
07.10.2008Renewal fee patent year 10
07.10.2009Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
31.10.200103   M06   Fee paid on   14.01.2002
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO9202246  (PARIKH INDU [US]);
 [X]WO9519785  (RES TRIANGLE PHARM LTD [US]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.